Shareholders Fight Bid To Dismiss Part Of Apotex Suit
The plaintiffs in a securities lawsuit accusing Bristol-Myers Squibb Co. and two former officers of deceiving investors with its controversial patent deal with Apotex Corp. are fighting an effort to toss...To view the full article, register now.
Already a subscriber? Click here to view full article